SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F
http://www.w3.org/2000/01/rdf-schema#comment
"overexpression of PEBP4 which we show to be a target of miR-34a reduces the sensitivity of lung cancer cells to cisplatin"
xsd:string
http://purl.uniprot.org/uniprot/#_4529F06303DDE1661A7B225C25044C67D05F10DBA4E02E2FC7B9178FBDA43ACB2ADFC8546B181D11D62F5F9B36F9D4AF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F
http://purl.uniprot.org/uniprot/Q96S96
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F
http://purl.uniprot.org/uniprot/#_Q96S96-mappedCitation-25038915
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C52C0E4456E890F5761D0A8EF864E50BF69FBF8BBCDFEAF8F6EEAD42E47DC8445248AB5A3F6244AD6E590F3013F64D7F